20.24
Roivant Sciences Ltd Aktie (ROIV) Neueste Nachrichten
Immunovant Announces Pricing of $550 Million Common Stock Financing - The Manila Times
Immunovant (Nasdaq: IMVT) raises $550M to support potential IMVT-1402 Graves’ launch - Stock Titan
Psivant Therapeutics, Inc. announced that it has received $47.5 million in funding from YK Bioventures, Samsara BioCapital LLC, Roivant Sciences Ltd., LSV Capital Management, LLC, Eurofarma Laboratórios S.A. and other investos - marketscreener.com
A former Roivant spinout bets on AI-designed drugs for immune conditions - Yahoo Finance
iSAM Funds UK Ltd Grows Stock Position in Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences stock hits all-time high at $21.36 By Investing.com - Investing.com Canada
Roivant Sciences stock hits all-time high at $21.36 - Investing.com
Roivant Sciences Ltd. $ROIV is SB Investment Advisers UK Ltd.'s 3rd Largest Position - MarketBeat
88,495 Shares in Roivant Sciences Ltd. $ROIV Acquired by Franklin Resources Inc. - MarketBeat
Cash per share of Roivant Sciences Ltd. – MUN:87S - TradingView
Roivant Sciences (NASDAQ:ROIV) Reaches New 52-Week HighWhat's Next? - MarketBeat
Affinity Asset Advisors LLC Purchases 250,000 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Earnings Beat: Why Roivant Sciences Ltd stock could rally in 2025Quarterly Portfolio Report & High Return Trade Guides - BỘ NỘI VỤ
Roivant Sciences Ltd. $ROIV Position Increased by Two Seas Capital LP - MarketBeat
Roivant Sciences Ltd. $ROIV Shares Sold by Pertento Partners LLP - MarketBeat
Is Roivant Sciences Ltd. stock safe for conservative investors2025 Winners & Losers & Daily Profit Focused Screening - Newser
Is Roivant Sciences Ltd. (87S) stock safe for risk averse investorsJuly 2025 Fed Impact & High Yield Stock Recommendations - Newser
Why Roivant Sciences Ltd. stock could rally in 2025Dividend Hike & Weekly Breakout Watchlists - Newser
How Roivant Sciences Ltd. (87S) stock compares with market leadersJuly 2025 Trends & Community Verified Trade Signals - Newser
Is Roivant Sciences Ltd. (87S) stock undervalued by metricsWeekly Trend Recap & High Conviction Buy Zone Alerts - Newser
Will Roivant Sciences Ltd. stock recover faster than peers2025 Market Overview & Capital Efficiency Focused Strategies - Newser
How Roivant Sciences Ltd. (87S) stock trades after rate cutsM&A Rumor & High Win Rate Trade Tips - Newser
Roivant Sciences Ltd. (ROIV) Stock Forecasts - Yahoo Finance
Why analysts recommend Roivant Sciences Ltd. (87S) stockJuly 2025 Sector Moves & Consistent Profit Trade Alerts - Newser
Is Roivant Sciences Ltd. (87S) stock prepared for digital transitionWeekly Trend Summary & Fast Entry High Yield Stock Tips - Newser
Why Roivant Sciences Ltd. (87S) stock signals breakout potential2025 Dividend Review & Risk Managed Investment Strategies - Newser
Rhumbline Advisers Reduces Stock Holdings in Roivant Sciences Ltd. $ROIV - MarketBeat
Can Roivant Sciences Ltd. (87S) stock survive global slowdownJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - Newser
Swiss National Bank Lowers Stake in Roivant Sciences Ltd. $ROIV - MarketBeat
Loomis Sayles & Co. L P Sells 352,443 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences (ROIV) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
(ROIV) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
33,356 Shares in Roivant Sciences Ltd. $ROIV Acquired by Inceptionr LLC - MarketBeat
Immunovant, Roivant slip after trial data for autoimmune disorder therapy - MSN
Volume Report: Why Roivant Sciences Ltd. stock could be next big winnerEarnings Miss & Precise Entry and Exit Recommendations - BỘ NỘI VỤ
Roivant Sciences Ltd. $ROIV is Tejara Capital Ltd's 10th Largest Position - MarketBeat
Bank Watch: Why Roivant Sciences Ltd. stock remains resilientJuly 2025 Reactions & Low Drawdown Momentum Ideas - moha.gov.vn
Te Ahumairangi Investment Management Ltd Increases Stock Holdings in Roivant Sciences Ltd. $ROIV - MarketBeat
SG Americas Securities LLC Has $489,000 Holdings in Roivant Sciences Ltd. $ROIV - MarketBeat
Growth Report: Why Roivant Sciences Ltd. stock is in analyst buy zoneWeekly Risk Summary & Weekly Return Optimization Alerts - BỘ NỘI VỤ
Can Roivant Sciences Ltd. stock double in next 5 years2025 Technical Overview & Fast Exit and Entry Strategy Plans - BỘ NỘI VỤ
Will Roivant Sciences Ltd. stock deliver shareholder valueQuarterly Performance Summary & Free Expert Verified Stock Movement Alerts - BỘ NỘI VỤ
Top Growth Companies With Strong Insider Ownership For November 2025 - Yahoo Finance UK
Why Roivant Sciences Ltd. stock could be next big winnerWeekly Loss Report & Weekly High Return Opportunities - BỘ NỘI VỤ
Rep. Lisa C. McClain Sells Off Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
QVT Financial LP Reduces Stake in Roivant Sciences Ltd - GuruFocus
Entropy Technologies LP Cuts Holdings in Roivant Sciences Ltd. $ROIV - MarketBeat
[Form 4] Roivant Sciences Ltd. Insider Trading Activity - Stock Titan
Pres Venker Surrenders 7,051 Of Roivant Sciences Ltd [ROIV] - TradingView
Indian-origin billionaire Vivek Ramaswamy’s 80% net worth surge is NOT all from US politics - financialexpress.com
Sunday’s Insider Moves: Major Buys at STAA, ANVS While ROIV Sees Selling By Investing.com - Investing.com Nigeria
Sunday’s Insider Moves: Major Buys at STAA, ANVS While ROIV Sees Selling - Investing.com Nigeria
Roivant Sciences Insider Sold Shares Worth $26,304,500, According to a Recent SEC Filing - marketscreener.com
Geode Capital Management LLC Cuts Stock Position in Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences Ltd. (87S.SG) Q4 FY2025 earnings call transcript - Yahoo Finance
QVT Financial LP sells Roivant Sciences (ROIV) shares worth $26.3 million - Investing.com Nigeria
Roivant Sciences director Manchester sells $26.3m in shares By Investing.com - Investing.com Nigeria
QVT Financial LP sells Roivant Sciences (ROIV) shares worth $26.3 million By Investing.com - Investing.com South Africa
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):